Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$2.45 USD
-0.10 (-3.92%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.45 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Earnings News For HRTX
-
Heron Therapeutics: Q4 Earnings Snapshot
-
Heron Therapeutics: Q3 Earnings Snapshot
-
Heron Therapeutics: Q2 Earnings Snapshot
-
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
-
Heron Therapeutics: Q1 Earnings Snapshot
-
Heron Therapeutics: Q4 Earnings Snapshot
-
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
-
Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates
-
Heron Therapeutics: Q3 Earnings Snapshot
-
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
-
Heron Therapeutics: Q2 Earnings Snapshot
-
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
-
Heron Therapeutics (HRTX) Reports Q4 Loss, Lags Revenue Estimates
-
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
-
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: Should You Buy?
-
Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
-
Will Heron Therapeutics (HRTX) Report Negative Q2 Earnings? What You Should Know
-
Heron Therapeutics (HRTX) Reports Q1 Loss, Misses Revenue Estimates
-
Will Heron Therapeutics (HRTX) Report Negative Q1 Earnings? What You Should Know
-
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
-
Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for
-
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
-
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates